The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study for tolerability, safety, and pharmacokinetics of pyrotinib, a novel irreversible HER2 and EGFR inhibitor, in Chinese patients with HER2+ metastatic breast cancer.
 
Binghe Xu
No Relationships to Disclose
 
Fei Ma
No Relationships to Disclose
 
Shanshan Chen
No Relationships to Disclose
 
Qiao Li
No Relationships to Disclose
 
Fan Yang
Employment - Jiangsu Hengrui Medicine
 
Yifan Zhang
No Relationships to Disclose
 
Xiaoyan Chen
No Relationships to Disclose
 
Dafang Zhong
No Relationships to Disclose
 
Ge Zhang
Employment - Jiangsu Hengrui Medicine